研究發展處

Neuroscience

1. Migraine 100%
2. Functional Magnetic Resonance Imaging 69%
3. Functional Connectivity 68%
4. Alzheimer's Disease 68%
5. Headache 67%
6. Cognitive Disorders 39%
7. Electroencephalogram 39%
8. Major Depressive Disorder 38%
9. Behavior (Neuroscience) 36%
10. Cognitive Function 35%
11. Magnetic Resonance Imaging 35%
12. Magnetic Resonance Imaging 34%
13. Mild Cognitive Impairment 33%
14. Cerebrovascular Accident 33%
15. Gray Matter Volume 33%
16. Parkinson's Disease 30%
17. Hippocampus 30%
18. In Vivo 28%
19. Brain Network 27%
20. Amygdala 24%
21. Diffusion Tensor Imaging 23%
22. Heart Rate Variability 23%
23. Blood Plasma 21%
24. Striatum 20%
25. Thalamus 20%
26. Gray Matter 19%
27. Obstructive Sleep Apnea 19%
28. Cerebellum 19%
29. Default Mode Network 19%
30. Receptor 17%
31. Nociception 15%
32. Gyri 15%
33. Antidepressant 15%
34. Mental Disorder 15%
35. Glutamic Acid 15%
36. Voxel-Based Morphometry 14%
37. Fractional Anisotropy 14%
38. Comorbidity 14%
39. Electrotherapy 14%
40. Sleep Quality 14%
41. Longitudinal Study 14%
42. Tractography 14%
43. Cluster Headache 14%
44. Attention Deficit Hyperactivity Disorder 13%
45. Pervasive Developmental Disorder 13%
46. Magnetoencephalography 13%
47. Evoked Potential 13%
48. Fluorine-18 13%
49. Brain Ischemia 13%
50. Frontal Lobe 13%
51. Prefrontal Cortex 13%
52. Gamma-Aminobutyric Acid 12%
53. Orbitofrontal Cortex 12%
54. Depressive Disorder 12%
55. Neurodegenerative Disorder 12%
56. Dopaminergic 12%
57. Neural Network 12%
58. Brain-Computer Interface 12%
59. Programmed Cell Death 12%
60. Positron Emission Tomography 11%
61. Putamen 11%
62. Subjective Cognitive Decline 11%
63. Metabolic Pathway 11%
64. Cerebrovascular Disease 11%
65. Brain-Derived Neurotrophic Factor 11%
66. Amyloid Protein 11%
67. Cerebral Cortex 11%
68. Ketamine 10%
69. In Vitro 10%
70. Transcranial Magnetic Stimulation 10%
71. Hypertension 10%
72. Medication Overuse 10%
73. Temporal Lobe 10%
74. Brain Areas 10%
75. Corpus Callosum 10%
76. Cingulate Cortex 10%
77. Posterior Cingulate 10%
78. Gene Expression 9%
79. Oxidative Stress 9%
80. Nervous System Disorder 9%
81. Brain Development 9%
82. Stem Cell 9%
83. Somatosensory Cortex 9%
84. Anterior Cingulate Cortex 9%
85. Epoxide Hydrolase 9%
86. Brain Age 9%
87. Treatment-Resistant Depression 9%
88. Interneuron 9%
89. Brain Disease 9%
90. Bipolar Disorder 9%
91. Neural Stem Cell 9%
92. Autism 8%
93. Anxiety Disorder 8%
94. Precuneus 8%
95. Central Nervous System 8%
96. Executive Function 8%
97. Cell Cycle 8%
98. Auras 8%
99. Astrocyte 8%
100. Motor Cortex 8%

Keyphrases

1. Migraine 73%
2. Taiwan 61%
3. Alzheimer's Disease 56%
4. Functional Connectivity 45%
5. Chronic Migraine 40%
6. Electroencephalography 38%
7. Functional Magnetic Resonance Imaging 37%
8. Major Depressive Disorder 37%
9. Healthy Controls 34%
10. Schizophrenia 34%
11. Headache 34%
12. Gray Matter Volume 32%
13. Taiwanese 29%
14. Cognitive Function 29%
15. Brain Regions 27%
16. Cognitive Impairment 27%
17. Parkinson's Disease 27%
18. Magnetoencephalography 26%
19. Reversible Cerebral Vasoconstriction Syndrome 25%
20. Mild Cognitive Impairment 24%
21. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 24%
22. Dementia 21%
23. Brain-computer Interface 21%
24. Older Adults 21%
25. Diffusion Tensor Imaging 20%
26. Hippocampus 20%
27. Confidence Interval 20%
28. Obstructive Sleep Apnea 20%
29. Magnetic Resonance Imaging 19%
30. Striatum 19%
31. Heart Rate Variability 19%
32. Migraine Patients 18%
33. Default Mode Network 18%
34. National Cohort Study 18%
35. Cluster Headache 17%
36. Electroencephalogram 16%
37. Resting State 15%
38. Neuroimaging 14%
39. Intracranial Hypotension 14%
40. Attention Deficit Hyperactivity Disorder 14%
41. Voxel-based Morphometry 14%
42. Amygdala 14%
43. Autism Spectrum Disorder 13%
44. White Matter 13%
45. Brain Networks 13%
46. Fractional Anisotropy 13%
47. Cerebellum 13%
48. Pathophysiology 12%
49. Aging 12%
50. Subjective Cognitive Decline 12%
51. Cognitive Decline 12%
52. Human Brain 12%
53. Brain Activity 12%
54. Odds Ratio 12%
55. Age-related 11%
56. Neurodegenerative Diseases 11%
57. Treatment-resistant Depression 11%
58. Primary Dysmenorrhea 11%
59. Episodic Migraine 11%
60. Positron Emission Tomography 11%
61. Healthy Adults 11%
62. Oxidative Stress 11%
63. Sleep Quality 11%
64. Neural Correlates 11%
65. Comorbidity 10%
66. Striatal 10%
67. Mini-Mental State Examination 10%
68. Protein Kinase 10%
69. Bipolar Disorder 10%
70. Ketamine 10%
71. Inflammation 10%
72. Apoptosis 10%
73. Hazard Ratio 10%
74. Anterior Cingulate Cortex 10%
75. Steady-state Visual Evoked Potential (SSVEP) 10%
76. Brain Structure 10%
77. White Matter Hyperintensities 10%
78. Medication Overuse Headache 10%
79. Single nucleotide Polymorphism 9%
80. Schizophrenic Patients 9%
81. Cortical Neurons 9%
82. Proteomic Analysis 9%
83. Sex Differences 9%
84. Hepatocellular Carcinoma 9%
85. Neural Stem Cells 9%
86. Rat Model 9%
87. Brain Aging 9%
88. Brain Connectivity 9%
89. Psychiatric Disorders 9%
90. Ischemic Stroke 9%
91. Antidepressants 9%
92. Cognitive Performance 9%
93. Cortex 9%
94. Taiwan Biobank 9%
95. Aging Effect 9%
96. Alzheimer's Disease Patient 9%
97. Amnestic Mild Cognitive Impairment (aMCI) 9%
98. Resting-state Functional Connectivity (rs-FC) 9%
99. Induced Pluripotent Stem Cells (iPSCs) 9%
100. CISD2 9%